Convetra Inc Completes Enrollment of a Third Clinical Trial Using Synovetin-OA

Today Serene LLC’s veterinary subsidiary, Convetra Inc, completed enrollment of a clinical trial involving reinjecting Synovetin-OA in client-owned dog with naturally occurring Grade 1-3 osteoarthritis of the elbow. These subjects will be followed for twelve months, with results reported in 2018.

Leave a Reply

Your email address will not be published. Required fields are marked *